PMID: 6160870Jan 1, 1981Paper

Haematological factors associated with proliferative retinopathy in homozygous sickle cell disease

The British Journal of Ophthalmology
R J HayesG R Serjeant

Abstract

Haematological indices were investigated in 261 patients with homozygous sickle cell disease, 29 of whom had developed proliferative sickle retinopathy (PSR). After allowing for age-related effects, male patients with high Hb (> 9 g/dl) and low HbF (< 5%) levels appeared to constitute a high risk group for PSR. This relationship was not evident in females, PSR being observed in patients with lower Hb and higher HbF levels than in the male group. PSR occurred in 14% of patients aged 40 years or over in this sample.

References

Jul 1, 1978·Stroke; a Journal of Cerebral Circulation·H TohgiM Kameyama
Nov 21, 1975·Documenta Ophthalmologica. Advances in Ophthalmology·P I Condon, G R Serjeant
Nov 1, 1972·American Journal of Ophthalmology·P I Condon, G R Serjeant
Dec 1, 1972·American Journal of Ophthalmology·P I Condon, G R Serjeant
Apr 1, 1974·Archives of Internal Medicine·F I Konotey-Ahulu
Apr 1, 1972·American Journal of Ophthalmology·P I Condon, G R Serjeant
Nov 1, 1970·British Journal of Haematology·G R Serjeant
Jun 1, 1980·The British Journal of Ophthalmology·P I Condon, G R Serjeant

❮ Previous
Next ❯

Citations

Jan 1, 1981·Transactions of the Royal Society of Tropical Medicine and Hygiene·G R Serjeant
Feb 1, 1997·Journal of Clinical Epidemiology·P W ThomasG R Serjeant
Jan 1, 1990·Eye·M S RoyA N Schechter
Jun 17, 1982·The New England Journal of Medicine·D R HiggsG R Serjeant
Jun 1, 1996·Archives of Disease in Childhood·A SinghalG Serjeant
Oct 1, 1981·The British Journal of Ophthalmology·R J HayesG R Serjeant
Nov 1, 1983·The British Journal of Ophthalmology·J F TalbotG R Serjeant
May 1, 1984·The British Journal of Ophthalmology·B E SerjeantG R Serjeant
Jul 1, 1986·The British Journal of Ophthalmology·B E SerjeantG R Serjeant
Oct 1, 1988·The British Journal of Ophthalmology·J F TalbotG R Serjeant
Mar 1, 1990·The British Journal of Ophthalmology·P D FoxG R Serjeant
Feb 1, 1993·The British Journal of Ophthalmology·P D FoxG R Serjeant
Aug 1, 1995·The British Journal of Ophthalmology·M S RoyD Giuliani
Sep 9, 2008·American Journal of Respiratory and Critical Care Medicine·Joanna E MacLeanPadmaja Subbarao
May 10, 2005·British Journal of Haematology·M H Steinberg
Apr 28, 2006·Acta Ophthalmologica Scandinavica·Carmen S P LimaSara T O Saad
Aug 29, 2013·Statistics in Medicine·Neal Alexander, Karim Anaya-Izquierdo
Jul 1, 1981·British Journal of Haematology·G R SerjeantB E Serjeant
Nov 1, 1983·British Journal of Haematology·M H SteinbergR F Rieder
Sep 1, 1987·Baillière's Clinical Haematology·J Stuart, C S Johnson
Oct 30, 2004·Hematology/oncology Clinics of North America·Charles T Quinn, Scott T Miller
May 26, 2016·Brazilian Oral Research·Shirlene Barbosa Pimentel FerreiraAntônio Paulino Ribeiro
Jun 30, 1992·Biochimica Et Biophysica Acta·R M Johnson, K Tang
May 1, 1981·Clinical Pediatrics·M C StevensG R Serjeant
Jul 25, 2017·Journal of Pediatric Hematology/oncology·Daniel A PahlRoyce W S Chen
Nov 9, 2011·The Korean Journal of Hematology·Sanjay PandeyRenu Saxena
Jan 1, 1989·Hemoglobin·S A Liebhaber
Nov 1, 1984·British Journal of Haematology·D W MilliganC S Scott
Jun 30, 2005·Blood·Vikki G NolanMartin H Steinberg
Jan 1, 1990·Annals of Tropical Paediatrics·M al-Salem, L Ismail
Jan 1, 1989·Annals of the New York Academy of Sciences·S H Embury
Jun 1, 1983·American Journal of Hematology·M H Steinberg, R P Hebbel
Dec 1, 1996·Hematology/oncology Clinics of North America·S K Ballas, N Mohandas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.